---
title: "Dutch Life Science Conference – Leiden"
id: "1770"
type: "post"
slug: "dutch-life-science-conference-leiden"
published_at: "2025-11-17T12:45:39+00:00"
modified_at: "2025-11-24T13:53:07+00:00"
url: "https://innocorepharma.com/news-events/dutch-life-science-conference-leiden/"
markdown_url: "https://innocorepharma.com/news-events/dutch-life-science-conference-leiden.md"
taxonomy_category:
  - "Events"
---

17 November 2025 | Events

# Dutch Life Science Conference – Leiden

# Meet InnoCore Pharmaceuticals at the Dutch Life Science Conference in Leiden – Unlock the Potential of Long-Acting Injectables for your API

Our Chief Technology Officer, [Rob Steendam](https://innocorepharma.com/company/people/rob-steendam/)
, Chief Business Officer, [Martin Bakker](https://innocorepharma.com/company/people/martin-bakker/)
, and Business Development Manager, [Vincent de Boer](https://innocorepharma.com/company/people/vincent-de-boer/)
, will be attending the [Dutch Life Science Conference](https://www.dutchlifesciences.com/)
 in Leiden, where we’ll be showcasing our latest advancements in biodegradable long-acting injectable (LAI) technologies.

## Join our presentation

Our co-founder and CTO Rob Steendam will go into detail during his presentation on how InnoCore’s [SynBiosys®](https://innocorepharma.com/technologies/synbiosys/)
 polymer platform enables sustained release of peptides and biologics—without the common limitations of PLGA, such as aggregation, acylation, or high local pH.

### Arrange a meeting

We would love to discuss how our drug delivery technologies can support your development goals. Reach out to us directly through the contact form below, or contact us on: [+31 50 575 3100](tel:+31%2050%20575%203100)

Related insights

[26 July 2018 | Funding InnoCore and Merck enter global collaboration Merck and InnoCore Pharmaceuticals to Improve Patient Compliance with New Drug Delivery Technology. Read the full story](https://innocorepharma.com/news-events/innocore-and-merck-enter-global-collaboration/)
[11 September 2020 | Funding Bill & Melinda Gates Foundation Grant Awarded InnoCore Pharmaceuticals has been awarded a grant by the Bill & Melinda Gates Foundation to develop a long-acting injectable contraceptive implant. Read the full story](https://innocorepharma.com/news-events/innocore-awarded-grant-by-the-bill-melinda-gates-foundation-in-contraception/)
[01 January 2021 | Funding InnoCore leads Consortium in Influenza vaccines InnoCore Pharmaceuticals has secured funding from the European Regional Development Fund to develop a biodegradable polymer-based microneedle array patch. Read the full story](https://innocorepharma.com/news-events/innocore-leads-consortium-in-influenza-vaccines/)